Literature DB >> 2248533

Corticosteroids in primary tuberculosis with bronchial obstruction.

M Toppet1, A Malfroot, M P Derde, V Toppet, M Spehl, I Dab.   

Abstract

The usefulness of prednisolone in combination with the modern potent antituberculous drugs has been studied in 29 children with primary lung tuberculosis and hilar adenopathy causing bronchial obstruction. These children were divided at random in two groups of 15 and 14 patients. Both groups were treated similarly except that one group received prednisolone. Both groups were very similar before the onset of treatment for most variables. Tuberculous infection healed in both groups but the group on steroids improved earlier and had significantly fewer complications, both on radiography and bronchoscopy. Only two of the patients on steroids still had progressive lesions: a very young baby probably because he developed two severe viral infections consecutively, and another infant of 7 months whose treatment was unreliable, as the parents were not very compliant. Some patients initially not treated with prednisolone improved only after it was given. Prednisolone treatment is not recommended when the reliability of the treatment cannot be guaranteed, as the hazard of harm would exceed the expected benefit.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2248533      PMCID: PMC1792610          DOI: 10.1136/adc.65.11.1222

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

1.  PREDNISONE THERAPY AS AN ADJUNCT IN THE TREATMENT OF LYMPH NODE-BRONCHIAL TUBERCULOSIS IN CHILDHOOD. A DOUBLE-BLIND STUDY.

Authors:  R L NEMIR; J CARDONA; A LACOIUS; M DAVID
Journal:  Am Rev Respir Dis       Date:  1963-08

2.  CORTICOSTEROIDS IN PULMONARY TUBERCULOSIS. I. OVER-ALL RESULTS IN MADISON-MINNEAPOLIS VETERANS ADMINISTRATION HOSPITALS STEROID STUDY.

Authors:  J R JOHNSON; B C TAYLOR; J F MORRISSEY; J W JENNE; F M MCDONALD
Journal:  Am Rev Respir Dis       Date:  1965-09

3.  Unusual ventilation-perfusion patterns in primary lung tuberculosis.

Authors:  J P Chanoine; M Toppet; I Dab; V Toppet; M Tondeur; H Ham; A Piepsz
Journal:  Pediatr Pulmonol       Date:  1988

4.  Prednisone as an adjunct in the chemotherapy of lymph node-bronchial tuberculosis in childhood: a double-blind study. II. Further term observation.

Authors:  R L Nemir; J Cardona; F Vaziri; R Toledo
Journal:  Am Rev Respir Dis       Date:  1967-03

Review 5.  Respiratory pharmacology. Antituberculosis drugs.

Authors:  P T Davidson; L Q Hanh
Journal:  Clin Chest Med       Date:  1986-09       Impact factor: 2.878

6.  Treatment of tuberculosis in children.

Authors:  M I Lorin; K H Hsu; S C Jacob
Journal:  Pediatr Clin North Am       Date:  1983-04       Impact factor: 3.278

7.  [Pediatric home care services in Belgium].

Authors:  M Toppet; A Dachy
Journal:  Arch Fr Pediatr       Date:  1977-12

Review 8.  The epidemiology of tuberculosis in the United States. Implications for diagnosis and treatment.

Authors:  A B Bloch; H L Rieder; G D Kelly; G M Cauthen; C H Hayden; D E Snider
Journal:  Clin Chest Med       Date:  1989-09       Impact factor: 2.878

Review 9.  Tuberculosis in children and adolescents.

Authors:  M H Smith
Journal:  Clin Chest Med       Date:  1989-09       Impact factor: 2.878

Review 10.  Modern approach to the diagnosis and treatment of tuberculosis in children.

Authors:  J R Starke
Journal:  Pediatr Clin North Am       Date:  1988-06       Impact factor: 3.278

  10 in total
  10 in total

Review 1.  Tracheobronchial tuberculosis.

Authors:  Vikas Pathak; Ray W Shepherd; Samira Shojaee
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

Review 2.  Endobronchial tuberculosis-a review.

Authors:  Talha Shahzad; Muhammad Irfan
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

3.  Two cases of pulmonary tuberculosis presenting with unilateral pulmonary hyperinflation in infancy.

Authors:  B Niggemann; U Klettke; K Magdorf; U Wahn
Journal:  Eur J Pediatr       Date:  1995-05       Impact factor: 3.183

4.  Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

5.  An unusual cause of bronchial obstruction.

Authors:  Ahmed Liju; Neel Sharma; Heather Milburn
Journal:  Lung India       Date:  2012-04

Review 6.  Clinical review: a systematic review of corticosteroid use in infections.

Authors:  Jody Aberdein; Mervyn Singer
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

7.  Tracheobronchial Tuberculosis Without Lung Involvement.

Authors:  Jeronimo Campos; Glenda Ernst; Eduardo Borsini; Artemio Garcia; Miguel Blasco; Martin Bosio; Alejandro Salvado
Journal:  J Clin Med Res       Date:  2015-06-09

8.  Corticosteroid effects on sputum culture in pulmonary tuberculosis: a meta-regression analysis.

Authors:  Robert S Wallis
Journal:  Open Forum Infect Dis       Date:  2014-06-03       Impact factor: 3.835

Review 9.  Corticosteroids as an adjunct to tuberculosis therapy.

Authors:  Charlotte Schutz; Angharad G Davis; Bianca Sossen; Rachel P-J Lai; Mpiko Ntsekhe; Yolande Xr Harley; Robert J Wilkinson
Journal:  Expert Rev Respir Med       Date:  2018-09-06       Impact factor: 3.772

Review 10.  Challenges in endobronchial tuberculosis: from diagnosis to management.

Authors:  Surender Kashyap; Anjali Solanki
Journal:  Pulm Med       Date:  2014-08-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.